Advances in vascular cognitive impairment

Stroke

Volumn 41, Issue 2, 2010, Pages

  Gorelick, Philip B ^a   Bowler, John V ^b  

^a UNIVERSITY OF ILLINOIS   (United States)

^b ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

Cardiovascular risk factors; Genetics; Neuroimaging; Vascular cognitive impairment

Indexed keywords

GLUCOSE;

ALZHEIMER DISEASE; BRAIN BLOOD VOLUME; BRAIN DAMAGE; BRAIN MAPPING; CARDIOVASCULAR RISK; CLINICAL FEATURE; COGNITIVE DEFECT; CORONARY ARTERY BYPASS GRAFT; DIABETES MELLITUS; DISEASE COURSE; GERIATRIC CARE; HIPPOCAMPUS; HISTOPATHOLOGY; HUMAN; LEUKOARAIOSIS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REVIEW; RISK FACTOR; VASCULAR AMYLOIDOSIS; CEREBROVASCULAR DISEASE; HYPERGLYCEMIA; MEMORY DISORDER; PATHOLOGY; PATHOPHYSIOLOGY; POSTOPERATIVE COMPLICATION; VASCULARIZATION;

CEREBRAL AMYLOID ANGIOPATHY; CEREBROVASCULAR DISORDERS; COGNITION DISORDERS; CORONARY ARTERY BYPASS; DIABETES COMPLICATIONS; HIPPOCAMPUS; HUMANS; HYPERGLYCEMIA; LEUKOARAIOSIS; MEMORY DISORDERS; POSTOPERATIVE COMPLICATIONS;

EID: 77449085137     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.109.569921     Document Type: Review

References (56)

1. Craft S. The role of metabolic disorders in Alzheimer disease and vascular dementia. Arch Neurol. 2009;66:300-305.
2. Wu W, Brickman AM, Luchsinger J, Ferrazzano P, Pichiule P, Yoshita M, Brown T, DeCarli C, Barnes CA, Mayeux R, Vannucci SJ, Small SA. The brain in the age of old: the hippocampal formation is targeted differentially by diseases of late life. Ann Neurol. 2008;64:698-706.
3. Tiehuis AM, van der Graaf Y, Visseren FL, Vincken KL, Biessels GJ, Appelman APA, Kappelle LJ, Mali WPTM, for the Smart Study Group. Diabetes increases atrophy and vascular lesions on brain MRI in patients with symptomatic arterial disease. Stroke. 2008;39:1600-1603.
4. Sonnen JA, Larson EB, Brickell K, Crane PK, Woltjer R, Montine TJ, Craft S. Different patterns of cérébral injury in dementia with or without diabetes. Arch Neurol. 2009;66:315-322.
5. Szabo K, Forster A, Jager T, Kern R, Griebe M, Hennerici MG, Gass A. Hippocampal lesion patterns in acute posterior cérébral artery stroke: clinical and MRI findings. Stroke. 2009;40:2042-2045.
6. Whitmer RA, Karter AJ, Yaffe K, Quesenberry CP Jr, Selby JV. Hypo-glycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus. JAMA. 2009;301:1565-1572.
7. Selnes OA, Grega MA, Bailey MM, Pham LD, Zeger SL, Baumgartner WA, McKhann GM. Cognition 6 years after surgical or medical therapy for coronary artery disease. Ann Neurol. 2008;63:581-590.
8. Newman MF, Kirchner JL, Phillips-Bute B, Gaver V, Grocott H, Jones RH, Mark DB, Reves JG, Blumenthal JA; Neurological Outcome Research Group and the Cardiothoracic Anesthesiology Research Endeavors Investigators. Longitudinal assessment of neurocognitive function after coronary-artery bypass surgery. N Engl J Med. 2001;344: 395-402.
9. Selnes OA, Grega MA, Bailey MM, Pham LD, Zeger SL, Baumgartner WA, McKhann GM. Do management strategies for coronary artery disease influence 6-year cognitive outcomes? Ann Thorac Surg. 2009;88: 445-454.
10. Yaffe K, Fiocco AJ, Lindquist K, Vittinghoff E, Simonsick EM, Newman AB, Satterfield S, Rosano C, Rubin SM, Ayonayon HN, Harris TB, for the Health ABC Study. Predictors of maintaining cognitive function in older adults: the Health ABC Study. Neurology. 2009;72:2029-2035.
11. Barnes DE, Covinsky KE, Whitmer RA, Kuller LH, Lopez OL, Yaffe K. Predicting risk of dementia in older adults: the late-life dementia risk index. Neurology. 2009;73:173-179.
12. Smith EE, Greenberg SM. B-amyloid, blood vessels, and brain function. Stroke. 2009;40:2601-2606.
13. Gorelick PB. cérébral microbleeds: evidence of heightened risk associated with aspirin use. Arch Neurol. 2009;66:691-693.
14. Pettersen JA, Sathiyamoorthy G, Gao F-Q, Szilagyi G, Nadkarni NK, St George-Hyslop P, Rogaeva E, Black SE. Microbleed topography, leuko-araiosis, and cognition in probable Alzheimer disease from the Sun-nybrook Dementia Study. Arch Neurol. 2008;65:790-795.
15. Cramer C, Haan MN, Galea S, Langa KM, Kalbfleisch JD. Use of statins and incidence of dementia and cognitive impairment without dementia in a cohort study. Neurology. 2008;71:344-350.
16. Vernooij MW, Haag MDM, van der Lugt A, Hofman A, Krestin GP, Stricker BH, Breteler MM. Use of antithrombotic drugs and the presence of cérébral microbleeds: the Rotterdam Scan Study. Arch Neurol. 2009; 66:714-720.
17. Scarmeas N, Luchsinger JA, Schupf N, Brickkman AM, Cosentino S, Tang MX, Stern Y. Physical activity, diet, and risk of Alzheimer disease. JAMA. 2009;302:627-637.
18. Scarmeas N, Stern Y, Mayeux R Manly JJ, Schupf N, Luchsinger JA. Mediterranean diet and mild cognitive impairment. Arch Neurol. 2009; 66:216-225.
19. Feart C, Samieri C, Rondeau V, Amieva H, Portet F, Dartigues J-F, Scarmeas N, Barberger-Gateau P. Adherence to a Mediterranean diet, cognitive decline, and risk of dementia. JAMA. 2009;302:638-648.
20. Breitner JCS, Haneuse SJPA, Walker R, Dublin S, Crane PK, Gray SL, Larson EB. Risk of dementia and AD with prior exposure to NSAIDs in an elderly community-based cohort. Neurology. 2009;72:1899-1905.
21. Trompet S, van Vliet P, de Craen AJ, Jolles J, Buckley BM, Murphy MB, Ford I, Macfarlane PW, Sattar N, Packard CJ, Stott DJ, Shepherd J, Bollen EL, Blauw GJ, Jukema JW, Westndorp RG. Pravastatin and cognitive function in the elderly: results of the PROSPER study. J Neurol. 2009; Aug 4 [E-pub ahead of print].
22. Solomon A, Kivipelto M, Wolozin B, Zhou J, Whitmer RA. Midlife serum cholesterol and increased risk of Alzheimer's and vascular dementia three decades later. Dement Geriatr Cogn Disord. 2009;4: 75-80.
23. Helzner EP, Luchsinger JA, Scarmeas N, Cosentino S, Brickman AM, Glymour M, Stern Y. Contribution of vascular risk factors to the progression in Alzheimer disease. Arch Neurol. 2009;66:343-348.
24. Hakansson K, Rovio S, Helkala EL, Vilska AR, Winblad B, Soininen H, Nissinen A, Mohammed AH, Kivipelto M. Association between mid-life marital status and cognitive function in later life: population based cohort study. BMJ. 2009;339:b1690.
25. Yaffe K, Weston AL, Blackwell T, Krueger KA. The metabolic syndrome and development of cognitive impairment among older women. Arch Neurol. 2009;66:324-328.
26. Kanaya AK, Lindquist K, Harris TB, Launer L, Rosano C, Satterfield S, Yaffe K, for the Health ABC Study. Total and regional adiposity and cognitive change in older adults. Arch Neurol. 2009;66:329-335.
27. Fitzpatrick AL, Kuller LH, Lopez OL, Diehr P, O'Meara ES, Longstreth WT, Luchsinger JA. Midlife and late-life obesity and the risk of dementia: Cardiovascular Health Study. Arch Neurol. 2009;66:336-342.
28. Cukierman-Yaffe T, Gerstein HC, Williamson JD, Lazar RM, Lovato L, Miller ME, Coker LH, Murray A, Sullivan MD, Marcovina SM, Launer LJ, for the Action to Control Cardiovascular Risk in Diabetes-Memory in Diabetes (ACCORD-MIND) investigators. Relationship between baseline glycemic control and cognitive function in individuals with type 2 diabetes and other cardiovascular risk factors. Diabetes Care. 2009;32: 221-226.
29. Stewart R, Xue Q-L, Masaki K, Petrovich H, Ross GW, White LR, Launer LJ. Change in blood pressure and incident dementia: a 32-year prospective study. Hypertension. 2009;54:233-240.
30. Sink KM, Leng X, Williamson J, Kritchevsky SB, Yaffe K, Kuller L, Yasar S, Atkinson H, Robbins M, Psaty B, Goff DC Jr. Angiotensin-converting enzyme inhibitors and cognitive decline in older adults with hypertension. Arch Intern Med. 2009;169:1195-1202.
31. Pieters B, Staals J, Knottnerus I, Rouhl R, Menheere P, Kessels A, Lodder J. Periventricular white matter lucencies relate to low vitamin B12 levels in patients with small-vessel stroke. Stroke. 2009;40:1623-1626.
32. de Lau LML, Smith AD, Refsum H, Johnston C, Breteler MMB. Plasma vitamin B12 status and cérébral white-matter lesions. J Neurol Neurosurg Psychiatry. 2009;80:149-157.
33. Vidal J-S, Dufouil C, Ducros V, Tzourio C. Homocysteine, folate and cognition in a large community-based sample of elderly people: the 3C Dijon study. Neuroepidemiology. 2008;30:207-214.
34. Seshadri S, Wolf PA, Beiser AS, Selhub J, Au R, Jacques PF, Yoshita M, Rosenberg IH, D'Agostino RB, DeCarli C. Association of plasma total homocysteine levels with subclinical brain injury: cérébral volumes, white matter hyperintensity, and silent brain infarcts at volumetric magnetic resonance imaging in the Framingham Offspring Study. Arch Neurol. 2008;65:642-649.
35. Lavallee PC, Labreuche J, Gongora-Rivera F, Jaramillo A, Brenner D, Klein IF, Touboul P-J, Vicaut E, Amarenco P, on behalf of the Lacunar-B.I.C.H.A.T. Investigators. Placebo-controlled trial of high-dose atorva-statin in patients with severe cérébral small-vessel disease. Stroke. 2009; 40:1721-1728.
36. Virtanen JK, Siscovick DS, Longstreth WT Jr, Kuller LH, Mozaffarian D. Fish consumption and risk of subclinical brain abnormalities on MRI in older adults. Neurology. 2008;71:439-446.
37. Price JF, Stewart MC, Deary IJ, Murray GD, Sandercock P, Butcher I, Fowkes FGR, on behalf of the AAA Trialists. Low dose aspirin and cognitive function in middle aged to elderly adults: randomised controlled trial. BMJ. 2008;337:a1198.
38. Bowler JV, Gorelick PB. Advances in vascular cognitive impairment 2006. Stroke. 2007;38:241-244.
39. Diener HC, Sacco RL, Yusuf S, Cotton D, Ounpuu S, Lawton WA, Palesch Y, Martin RH, Albers GW, Bath P, Bornstein N, Chan BP, Chen ST, Cunha L, Dahlof B, De Keyser J, Donnan GA, Estol C, Gorelick P, Gu V, Hermansson K, Hilbrich L, Kaste M, Lu C, Machnig T, Pais P, Roberts R, Skvortsova V, Teal P, Toni D, Vandermaelen C, Voigt T, Weber M, Yoon BW, for the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) study group. Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the prevention regimen for effectively avoiding second strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study. Lancet Neurol. 2008;7:875-884.
40. Peters R, Beckett N, Forette F, Tuomilehto J, Clarke R, Ritchie C, Waldman A, Walton I, Poulter R, Ma S, Comsa M, Burch L, Fletcher A, Bulpitt C. Incident dementia and blood pressure lowering in the HYpertension in the Very Elderly Trial COGnitive function assessment (HYVET-COG): a double-blind, placebo controlled trial. Lancet Neurol. 2008;7:683-689.
41. Young VG, Halliday GM, Kril JJ. Neuropathologic correlates of white matter hyperintensities. Neurology. 2008;71:804-811.
42. Simpson JE, Hosny O, Wharton SB, Heath PR, Holden H, Fernando MS, Matthews F, Forster G, O'Brien JT, Barber R, Kalaria RN, Brayne C, Shaw PJ, Lewis CE, Ince PG, on behalf of the Medical Research Council Cognitive Function and Ageing Study Neuropathology Group. Microarray RNA expression analysis of cérébral white matter lesions reveals changes in multiple functional pathways. Stroke. 2009;40: 369-375.
43. O'Sullivan M, Summers PE, Jones DK, Jarosz JM, Williams SC, Markus HS. Normal-appearing white matter in ischemic leukoaraiosis: a diffusion tensor MRI study. Neurology. 2001;57:2307-2310.
44. Segura B, Jurado MA, Freixenet N, Falcon C, Junque C, Arboix A. Microstructural white matter changes in metabolic syndrome: a diffusion tensor imaging study. Neurology. 2009;73:438-444.
45. Viswanathan A, Patel P, Rahman R, Nandigam RNK, Kinnecom C, Bracoud L, Rosand J, Chabriat H, Greenberg SM, Smith EE. Tissue microstructural changes are independently associated with cognitive impairment in cérébral amyloid angiopathy. Stroke. 2008;39:1988-1992.
46. Buyck J-F, Dufouil C, Mazoyer B, Maillard P, Ducimetiere P, Alp-erovitch A, Bousser M-G, Kurth T, Tzourio C. cérébral white matter lesions are associated with the risk of stroke but not with other vascular events: the 3-City Dijon study. Stroke. 2009;40:2327-2331.
47. Troncoso JC, Zonderman AB, Resnick SM, Crain B, Pletnikova O, O'Brien RJ. Effect of infarcts on dementia in the Baltimore longitudinal study of aging. Ann Neurol. 2008;64:168-176.
48. Paternoster L, Chen W, Sudlow CLM. Genetic determinants of white-matter hyperintensities on brain scans: a systematic assessment of 19 candidate gene polymorphisms in 46 studies in 19 000 subjects. Stroke. 2009;40:2020-2026.
49. Turner ST, Fornage M, Jack CR Jr, Mosley TH, Knopman DS, Kardia SLR, Boerwinkle E, de Andrade M. Genomic susceptibility loci for brain atrophy, ventricular volume, and leukoaraiosis in hypertensive sibships. Arch Neurol. 2009;66:847-857.
50. van Dijk EJ, Prins ND, Vrooman HA, Hofman A, Koudstaal PJ, Breteler MMB. Progression of cérébral small-vessel disease in relation to risk factors and cognitive consequences: Rotterdam Scan Study. Stroke. 2008; 39:2712-2719.
51. Dufouil C, Godin O, Chalmers J, Coskun O, MacMahon S, Tzourio-Mazoyer N, Bousser M-G, Anderson C, Mazoyer B, Tzourio C, for the Progress MRI Substudy Investigators. Severe cérébral white matter hyperintensities predict severe cognitive decline in patients with cerebro-vascular disease history. Stroke. 2009;40:2219-2221.
52. Inzitari D, Pracucci G, Poggesi A, Carlucci G, Barkhof F, Chabriat H, Erkinjuntti T, Fazekas F, Ferro JM, Hennerici M, Langhorne P, O'Brien J, Scheltens P, Visser MC, Wahlund L-O, Waldemar G, Wallin A, Pantoni L, on behalf of the LSG. Changes in white matter as determinant of global functional decline in older independent outpatients: three year follow-up of LADIS (leukoaraiosis and disability) study cohort. BMJ. 2009;339:b2477.
53. Silbert LC, Howieson DB, Dodge H, Kaye JA. Cognitive impairment risk: white matter hyperintensity progression matters. Neurology. 2009; 73:120-125.
54. Bohnen NI, Muller MLTM, Kuwabara H, Constantine GM, Studenski SA. Age-associated leukoaraiosis and cortical cholinergic deafferen-tation. Neurology. 2009;72:1411-1416.
55. Benisty S, Gouw AA, Porcher R, Madureira S, Hernandez K, Poggesi A, van der Flier WM, Van Straaten ECW, Verdelho A, Ferro J, Pantoni L, Inzitari D, Barkhof F, Fazekas F, Chabriat H, on behalf of the LADIS Study group. Location of lacunar infarcts correlates with cognition in a sample of non-disabled subjects with age-related white-matter changes: the LADIS study. J Neurol Neurosurg Psychiatry. 2009;80:478-483.
56. Blahak C, Baezner H, Pantoni L, Poggesi A, Chabriat H, Erkinjuntti T, Fazekas F, Ferro JM, Langhorne P, O'Brien J, Visser MC, Wahlund LO, Waldemar G, Wallin A, Inzitari D, Hennerici MG, on behalf of the LSG. Deep frontal and periventricular age related white matter changes but not basal ganglia and infratentorial hyperintensities are associated with falls: cross sectional results from the LADIS study. J Neurol Neurosurg Psychiatry. 2009;80:608-613.